Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

SFRS2B Inhibitors

The chemical class termed SFRS2B Inhibitors encompasses a group of compounds meticulously designed to selectively target the molecular entity SFRS2B. SFRS2B belongs to the serine/arginine-rich splicing factor (SRSF) family, crucial players in the process of RNA splicing. These splicing factors, including SFRS2B, modulate the splicing of precursor mRNA molecules into mature mRNA, influencing gene expression and protein diversity. Despite the recognized importance of SFRS2B in cellular processes, the intricate details of its functions and interactions within the context of RNA splicing are subjects of active investigation. Inhibitors within the SFRS2B Inhibitors class represent intricately engineered molecules with the primary objective of modulating the activity or function of SFRS2B, thereby inducing an inhibitory effect. Researchers in this field employ a multifaceted approach, integrating insights from structural biology, medicinal chemistry, and computational modeling to unravel the complex molecular interactions between the inhibitors and the target SFRS2B.

Structurally, SFRS2B Inhibitors are characterized by specific molecular features designed to facilitate selective binding to SFRS2B. This selectivity is crucial to minimize unintended effects on other cellular components, ensuring a focused impact on the intended molecular target. The development of inhibitors within this chemical class involves a comprehensive exploration of structure-activity relationships, optimization of pharmacokinetic properties, and a deep understanding of the molecular mechanisms associated with SFRS2B. As researchers delve deeper into the functional aspects of SFRS2B Inhibitors, the knowledge generated contributes not only to deciphering the specific roles of SFRS2B but also to advancing our broader comprehension of RNA splicing and its regulatory networks within cells. The exploration of SFRS2B Inhibitors stands as a significant avenue for expanding fundamental knowledge in molecular pharmacology and cellular biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$299.00
$5699.00
$11099.00
$25500.00
$66300.00
$2875.00
63
(2)

Pladienolide B is known to bind to the spliceosome, disrupting splicing and potentially affecting the expression of splicing factors like SFRS2B.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide causes DNA damage by inhibiting topoisomerase II, which can lead to changes in gene expression, possibly affecting SFRS2B.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Camptothecin inhibits topoisomerase I, leading to DNA damage and potential alteration in gene expression, which may include SFRS2B.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

DRB is a transcription inhibitor that specifically inhibits RNA polymerase II, potentially decreasing the transcription of genes including SFRS2B.